Log In
Print
BCIQ
Print
Print this Print this
 

ISIS-FGFR4Rx

  Manage Alerts
Collapse Summary General Information
Company Isis Pharmaceuticals Inc.
DescriptionInhibitor of fibroblast growth factor receptor 4 (FGFR4)
Molecular Target Fibroblast growth factor (FGF) receptor 4 (FGFR4) (CD334)
Mechanism of ActionAntisense therapy; Fibroblast growth factor (FGF) receptor antagonist
Therapeutic ModalityNucleic acid: Linear RNA: Antisense
Latest Stage of DevelopmentPhase I
Standard IndicationObesity
Indication DetailsTreat obesity
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today